Polymeric systems for amorphous Delta9-tetrahydrocannabinol produced by a hot-melt method. Part II: Effect of oxidation mechanisms and chemical interactions on stability.
The objectives of the present research investigations were to (i) elucidate the mechanism for the oxidative degradation of Delta(9)-tetrahydrocannabinol (THC) in polymer matrix systems prepared by a hot-melt fabrication procedure, and (ii) study the potential for controlling these mechanisms to reduce the degradation of THC in solid dosage formulations. Various factors considered and applied included drug-excipient compatibility, use of antioxidants, cross-linking in polymeric matrices, microenvironment pH, and moisture effect. Instability of THC in polyethylene oxide (PEO)-vitamin E succinate (VES) patches was determined to be due to chemical interaction between the drug and the vitamin as well as with the atmospheric oxygen. Of the different classes and mechanisms of antioxidants studied, quenching of oxygen by reducing agents, namely, ascorbic acid was the most effective in stabilizing THC in PEO-VES matrices. Only 5.8% of the drug degraded in the ascorbic acid-containing patch as compared to the control (31.6%) after 2 months of storage at 40 degrees C. This coupled with the cross-linking extent and adjustment of the pH microenvironment, which seemed to have an impact on the THC degradation, might be effectively utilized towards stabilization of the drug in these polymeric matrices and other pharmaceutical dosage forms. These studies are relevant to the development of a stable transmucosal matrix system for the therapeutic delivery of amorphous THC.
Munjal
Manish
M
Department of Pharmaceutics, School of Pharmacy, The University of Mississippi, University, Mississippi 38677-1848, USA.
Elsohly
Mahmoud A
MA
Repka
Michael A
MA
D000975:Antioxidants / Q000737:chemistry; D002626:Chemistry, Pharmaceutical; D003432:Cross-Linking Reagents; D013759:Dronabinol / Q000737:chemistry*; D004355:Drug Stability; D005079:Excipients; D006813:Humidity; D006863:Hydrogen-Ion Concentration; D010084:Oxidation-Reduction; D011092:Polyethylene Glycols; D011108:Polymers; D013818:Thermogravimetry; D024505:Tocopherols; D014810:Vitamin E / Q000031:analogs & derivatives
D000975:Antioxidants; D003432:Cross-Linking Reagents; D005079:Excipients; D011108:Polymers; D014810:Vitamin E; D011092:Polyethylene Glycols; D013759:Dronabinol; D024505:Tocopherols